Sermorelin: Reference Overview and Reconstitution Notes

Sermorelin research image
For research and educational reference only. Preppin Peppers sells laboratory hardware and materials (reconstitution pens, cartridges, and bacteriostatic water); it does not sell peptides or any substance for consumption. This is educational content, not medical, health, veterinary, dosing, or compounding advice, has not been evaluated by the FDA, and is not intended to diagnose, treat, cure, or prevent any condition, or for human or animal use. Comply with the laws that apply to you and consult a licensed professional for any health decision.

Sermorelin is a man-made peptide (a short chain of amino acid building blocks) that copies part of a natural hormone. It is studied in research for how it signals the body to release growth hormone. It is for research use only, has no active FDA-approved product on the market, and is banned in sport under the WADA (World Anti-Doping Agency) rules.

Sermorelin


What it is

Chemical structure of Sermorelin
The chemical structure of Sermorelin.

Sermorelin is a man-made peptide. A peptide is a short chain of tiny building blocks called amino acids, like beads lined up on a string. Sermorelin matches the first 29 amino acids of human growth-hormone-releasing hormone (GHRH), a natural hormone the body produces. This short segment is considered the smallest piece of GHRH that still does the full job.

It belongs to the GHRH-analog family (meaning it is built to mimic natural GHRH). It is also called a growth-hormone secretagogue, which simply means a substance that signals the body to produce and release growth hormone. It works by attaching to special docking sites called receptors in the pituitary gland (a small gland at the base of the brain), instead of delivering growth hormone directly.

Key point: Sermorelin works as a growth-hormone secretagogue. It signals the pituitary gland to release its own growth hormone, rather than adding outside growth hormone directly.


Research context and categorization

Sermorelin is grouped with growth-hormone secretagogues and GHRH analogs. It also appears in research on aging and longevity.

Mechanisms and Applications

In research, Sermorelin is studied mainly for how it prompts the pituitary gland to release its own growth hormone in a pulsatile pattern. Pulsatile means in short natural bursts, the way a pump fires in quick spurts rather than running in one steady stream. Researchers have also looked at how it affects IGF-1 (insulin-like growth factor 1), a protein the body makes in response to growth hormone.

Researchers also study its effect on age-related drops in growth-hormone output, body composition, and sleep quality in older adults whose growth-hormone levels have declined over time.

Regulatory Considerations

There is currently no active FDA-approved Sermorelin product on the market. Because of that, any use outside its former approved use in children should be treated as investigational (meaning still under study, not confirmed or approved). The outcomes described in the research literature are areas of ongoing study and are not confirmed or approved benefits.


Status

  • Regulatory status: Sermorelin was formerly FDA-approved (sold as Geref, approved in 1997) for growth-hormone deficiency in children. The commercial product was discontinued around 2008 for business reasons unrelated to safety or effectiveness. There is no active FDA-approved commercial product today, so it is handled as a research-only or compounded material rather than an approved drug.
  • Sport status: Sermorelin is banned under the WADA Prohibited List. It falls under category S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics) in the growth-hormone releasing factors group, and is banned at all times, both in and out of competition.

Reconstitution notes (general)

Sermorelin is usually supplied as a lyophilized (freeze-dried) powder. Think of it like instant coffee: the water has been removed to make it shelf-stable, and you add liquid back before use. That process of adding liquid back is called reconstitution. For lab work, bacteriostatic water (sterile water that contains a small preservative to slow bacterial growth) is used. The concentration you get equals the milligrams of peptide in the vial divided by the milliliters of water added.

Adding more water gives a lower concentration per unit volume. Adding less water gives a higher concentration. To figure out the exact concentration for your vial and water volume, use the peptide calculator.


Dilution and handling notes (compound-specific)

Because Sermorelin is a true lyophilized powder, it must be reconstituted before lab use. Vial sizes listed in reference material commonly fall in the few-milligram range (for example, around 5 mg).

Typical water volumes fall in roughly the 1 to 5 mL range, depending on vial size and the concentration a protocol requires. More water gives a lower, easier-to-measure concentration. Less water gives a more concentrated, smaller-volume solution.

Reconstitution Technique

Sermorelin dissolves easily into a clear, colorless liquid. It is not one of the peptides that tends to gel or resist dissolving. When water is guided gently down the inner glass wall of the vial and the vial is swirled slowly, the powder cake usually goes fully into solution within a couple of minutes.

Because it dissolves so readily, heavy cloudiness, persistent specks, or any discoloration are signs of a problem with the material or the mix, not normal behavior. These are reasons to discard the solution rather than keep swirling.

Handling Best Practices

The main handling concerns are about physical stress and environment, not about difficulty dissolving. When working with this peptide, follow these steps:

  • Do not shake the vial: Shaking creates foam, and that physical stress can break down the peptide. Slow swirling is the right approach.
  • Direct the water stream carefully: Aim the stream against the inner glass wall, not directly onto the powder, to reduce physical stress on the material.
  • Protect from light and heat: Peptides in this family are sensitive to both. Keep the reconstituted vial cold and away from light between uses.

Handling and storage

To keep the reconstituted peptide stable, follow these storage steps:

  • Refrigerate the reconstituted vial at 2 to 8 degrees Celsius and keep it away from direct light.
  • Wipe the rubber stopper with an alcohol swab before each puncture.
  • Label the vial with the reconstitution date so you always know how old the solution is.
  • Use a conservative window of roughly four weeks as a default for refrigerated reconstituted solution, and inspect it before every use.
  • Discard any solution that looks cloudy, discolored, or has floating particles.


Tools and supplies

Macro of Sermorelin lyophilized powder
Close detail of the lyophilized powder.

Reminder: research and educational reference only. Preppin Peppers sells hardware and materials, not peptides. Not medical, dosing, or health advice, not evaluated by the FDA, and not intended for human or animal use.



Frequently asked questions

What is Sermorelin and how does it work in laboratory research?

Sermorelin is a synthetic peptide matching the first 29 amino acids of GHRH. It binds pituitary receptors to stimulate pulsatile growth-hormone release, classifying it as a growth-hormone secretagogue studied for GH-signaling research.

Is Sermorelin currently FDA-approved?

No active FDA-approved Sermorelin product exists today. It was formerly approved as Geref (1997) for pediatric GH deficiency but discontinued around 2008 for business reasons. It is now handled as a research-only or compounded material.

Is Sermorelin banned in sport?

Yes. Sermorelin is listed on the WADA Prohibited List under category S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics) and is banned at all times, both in and out of competition.

What the research community gets wrong about Sermorelin

  • It is not synthetic growth hormone. Sermorelin is only the first 29 amino acids of GHRH, a signaling peptide. The vial on your bench holds a short GHRH fragment, not a growth hormone (HGH) preparation, so it should not be filed next to HGH reference material.
  • "GHRH (1-29)" and "sermorelin" are the same core sequence. Catalogs may list the material under different names or as the acetate salt form. Match the amino acid sequence and the PubChem CID, not the trade name, so two vials do not get logged as different compounds.
  • Easy to dissolve does not mean hard to damage. The powder clears into a colorless liquid within a couple of minutes, which fools people into treating it as stable. Solubility and stability are separate things. It still breaks down from heat, light, and the shear stress of shaking (foam), so a fast, clean mix is not permission to skip cold, dark storage.
  • "No FDA-approved product" does not mean discredited. The old commercial product (Geref) was pulled for business reasons, not because the compound failed. A blank search in a drug-label database means no active label, not that the material is absent from the scientific literature.
  • A clear vial is not proof of an intact peptide. Clarity only tells you nothing has visibly clumped or fallen out of solution. Peptide can degrade while the liquid still looks clear, so date the vial and treat clarity as one check, not the whole answer, on how long a reconstituted solution has held up.

From our bench: If you have reconstituted a sermorelin vial, tell us how long the powder cake took to go fully clear after you guided the bacteriostatic water down the inner glass wall and swirled slowly, and at what water volume and room temperature you were working. Note whether you saw any haze or specks along the way. We will not post invented numbers, so real timings and observations from your own bench are what help other researchers set their expectations.


Sources

  1. Bacteriostatic Water for Injection, USP , FDA/DailyMed label (0.9% benzyl alcohol)
  2. Duerkop et al., Biotechnol J 2018 , Impact of Cavitation, High Shear Stress and Air/Liquid Interfaces on Protein Aggregation
  3. Sigma-Aldrich (Merck) , Handling and Storage Guidelines for Peptides and Proteins
  4. PubChem , Sermorelin (compound record, GHRH analog)
  5. Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999;12(2):139-57.
  6. Barabutis N. A glimpse at growth hormone-releasing hormone cosmos. Clin Exp Pharmacol Physiol. 2020;47(9):1632-1634.

✔ Reviewed by Bryan Le, PharmD, RPh

Bryan is a licensed pharmacist (Doctor of Pharmacy, Registered Pharmacist). Reconstituting lyophilized preparations is core pharmacy practice, so he reviews The Lab’s content for technical accuracy and to keep it within a research-and-education scope, with no medical or dosing advice. View profile on LinkedIn.

Get more of The Lab in your Google results
Browse The Lab by topic